SSCI Leading Fund
上海国投先导
SSCI Leading Fund (上海国投先导基金 / 上海国投先导私募基金管理有限公司) is a Shanghai state-owned investment fund — elsewhere's corpus covers it mainly through its 2025–2026 deal activity and ecosystem events rather than a dedicated profile. On the investment side, in 2026 it co-led NewPro Bioworks' tens-of-millions RMB Pre-A round alongside Aochuang Leading Fund , joined Loyal Valley Capital's nearly 500 million yuan Series C in YolTech Therapeutics , and — notably — made its first joint foray into embodied AI with the Beijing Robotics Industry Development Investment Fund, participating in Tashi Zhihang's $455M Pre-A round, framed by Linear Capital as aligning with the national "15th Five-Year Plan" robotics direction and positioning Tashi as a regional embodied-AI chain-leader . It also shows up as an ecosystem organizer: co-hosting an AI for Science salon with FreeS Fund and the Caohejing AI Accelerator in mid-2026 , and partnering with Dalton Venture on an AI4S event in August 2026 . On personnel, Zhi Wen (温治) is its general manager , with He Miao (何苗) as deputy general manager . Details like founding date, fund size, and LP structure are not covered in elsewhere's corpus.
AI-generated — may contain errors, please verify.
Coverage
When AI Starts Doing Science: A Recap of the SSCI Leading Fund × Dalton Venture Tong Academy Event
Scientific exploration has no end point, and innovation in the age of intelligence has only just begun.
What Happens After AI Starts Doing Science? | Dalton Venture AI4S Event Registration Now Open
More than 2,000 years ago, humanity gazed up at the stars, probing the laws of the cosmos. Three centuries ago, scientists built the modern scientific framework through experimentation and mathematics. Every leap in scientific development has been accompanied by new tools, new methods — and shifts in how humans explore the unknown.
"NewPro" Raises Tens of Millions of RMB in Pre-A Round; Linear Capital Led Angel Round | Linear Portfolio
Focused on the bio-manufacturing of scarce functional proteins found in nature.
NewPro Closes Tens of Millions of RMB in Pre-A Funding Led by Dalton Venture and SSCI Leading Fund, Achieves FDA Self-GRAS Certification for Self-Developed Lactoferrin | Dalton Venture News
Recently, **NewPro Bioworks (Shanghai Xinyicui Biotechnology Co., Ltd.) announced the completion of a Pre-A funding round worth tens of millions of RMB**. This round was jointly led by **SSCI Leading Fund and Aochuang Pioneer Fund — the latter established by Dalton Venture in partnership with listed industry player OPM Biosciences, making it the first bio-manufacturing industry CVC fund in the Yangtze River Delta region**. Meanwhile, the company's self-developed precision-fermented lactoferrin product
Dalton Venture's Sun Qi: Dig Deep Into Your Own Track, and Wait for Your Own Market | Dalton Insights
Over the past year, TongDao's main focus areas have been three: brain-computer interfaces, bio-manufacturing, and new materials.
Has the Inflection Point for AI for Science Arrived?
Where will the next Nobel Prize emerge?
Has the Inflection Point for AI for Science Arrived?
Where will the next Nobel Prize emerge?
YolTech Therapeutics Closes Nearly 500 Million Yuan Series C Round Led by Loyal Valley Capital | Unity Ventures Portfolio News
The company with the most in-vivo gene editing pipelines in clinical stages worldwide
BlueRun Ventures' Angel Project Tashi Zhihang Closes $455M Pre-A Round to Build Robots That "Actually Work and Actually Ship" | BlueRun Family
Let China's Embodied Intelligence Take the World Stage
"Tashi Intelligent Navigation" Raises $455 Million in Pre-A Round, Linear Capital Continues to Back Through Three Consecutive Rounds Since Seed Stage | Linear Portfolio
China's embodied intelligence sector has set two all-time fundraising records simultaneously.
Jieti Medical Closes 500 Million Yuan Strategic Round; Source Code Capital Co-Led Previous Round
Source Code Capital continued to follow on in this round as an existing shareholder. In the previous round, Source Code Capital was a co-lead investor.
Qiming Venture Partners' 16th RMB Fund Annual Meeting and Investor Summit Successfully Held in Shanghai
China's high-quality companies have reached a valuation level that's become genuinely attractive.
